Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis | Published in Journal of Health Economics and Outcomes Research

Loading [Contrib]/a11y/accessibility-menu.js

Metrics
Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis

Ci Song, Peter Kunovszki, Amélie Beaudet,

pulmonary arterial hypertensionselexipagiloprosttreprostinilhospitalizationhealthcare resource utilizationretrospective database analysis

• https://doi.org/10.36469/001c.35246

Pageviews and PDF downloads

Pageviews Downloads

11 past 30 days

Last 7 days Last 30 days Last 90 days All time

Top Countries
TR	6
KR	2
US	2
GB	1